Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 12,164,633
  • Shares Outstanding, K 142,610
  • Annual Sales, $ 5,281 M
  • Annual Income, $ -4,012,800 K
  • 36-Month Beta 0.69
  • Price/Sales 2.34
  • Price/Cash Flow 10.70
  • Price/Book 2.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.10 +12.09%
on 08/30/17
89.87 -5.09%
on 09/13/17
+8.03 (+10.39%)
since 08/18/17
3-Month
63.68 +33.95%
on 08/09/17
89.87 -5.09%
on 09/13/17
+12.16 (+16.63%)
since 06/19/17
52-Week
63.68 +33.95%
on 08/09/17
99.14 -13.96%
on 09/23/16
-7.98 (-8.55%)
since 09/19/16

Most Recent Stories

More News
Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel

Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Acanya® (clindamycin phosphate and benzoyl...

PRGO : 85.30 (-1.52%)
Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick

Perrigo's (PRGO) shares rise with Jeff Smith, CEO of Starboard Value, certifying the company as a top investment pick, courtesy its highly potential generic business.

AABA : 67.43 (+0.48%)
ACAD : 36.55 (-1.16%)
AMZN : 969.86 (-0.44%)
PRGO : 85.30 (-1.52%)
Perrigo Company To Present At Upcoming Investor Conferences

Perrigo Company plc (NYSE: PRGO; TASE) today announced that John T. Hendrickson, Perrigo Chief Executive Officer, will present at the 2017 Wells Fargo Healthcare Conference at 4:10 PM EDT on Wednesday,...

WFC : 53.36 (+1.23%)
MS : 47.67 (+0.74%)
PRGO : 85.30 (-1.52%)
Perrigo's (PRGO) OTC Version of Nexium Secures FDA Approval

Perrigo (PRGO) gains an FDA consent for the OTC version of AstraZeneca's Nexium post the ongoing patent lawsuit settlement through an agreement.

AZN : 32.67 (+0.77%)
GSK : 39.92 (-0.32%)
ADRO : 11.00 (-1.35%)
PRGO : 85.30 (-1.52%)
Perrigo reports final US FDA approval for upcoming launch & settlement of store brand OTC equivalent of Nexium 24HR capsules

Healthcare company Perrigo Company plc (NYSE:PRGO) (TASE:PRGO) reported on Monday the receipt of final approval from the US Food & Drug Administration for the store brand OTC equivalent of Nexium 24HR...

PRGO : 85.30 (-1.52%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Internation (ENDP, LCI, SUPN, TXMD, PRGO)

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

LCI : 16.55 (-1.78%)
ENDP : 8.39 (+0.60%)
SUPN : 38.05 (-23.36%)
TXMD : 6.32 (-4.96%)
PRGO : 85.30 (-1.52%)
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream

Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Mycolog®...

PRGO : 85.30 (-1.52%)
The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant

The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant

ESPR : 49.57 (-1.86%)
MYL : 30.98 (-1.65%)
ZYNE : 6.30 (-1.87%)
VRX : 13.77 (-0.15%)
PRGO : 85.30 (-1.52%)
Company News For August 11, 2017

Companies in the new are: PRGO,KSS,EAT,LYV

LYV : 43.19 (+2.42%)
EAT : 32.01 (-0.96%)
KSS : 45.38 (+1.09%)
PRGO : 85.30 (-1.52%)
Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure

This week, focus was on earnings announcements from companies like Mylan (MYL), Perrigo and Endo.

ESPR : 49.57 (-1.86%)
MYL : 30.98 (-1.65%)
MRK : 65.95 (-0.06%)
ZYNE : 6.30 (-1.87%)
VRX : 13.77 (-0.15%)
BMY : 62.93 (+0.37%)
PRGO : 85.30 (-1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Support & Resistance

2nd Resistance Point 87.62
1st Resistance Point 86.46
Last Price 85.30
1st Support Level 84.57
2nd Support Level 83.84

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.